Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Reexamination Certificate
2005-04-25
2011-11-15
Chandra, Gyan (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
C530S402000, C424S085100
Reexamination Certificate
active
08058398
ABSTRACT:
The present invention relates to granulocyte colony-stimulating factor (“G-CSF”) hybrid molecules which retain the internal core helices of G-CSF. Also provided are pharmaceutical compositions containing hybrid molecules.
REFERENCES:
patent: 4810643 (1989-03-01), Souza
patent: 4853871 (1989-08-01), Pantoliano et al.
patent: 4904584 (1990-02-01), Shaw
patent: 4908773 (1990-03-01), Pantoliano et al.
patent: 5023802 (1991-06-01), Fujita et al.
patent: 5025388 (1991-06-01), Cramer, III et al.
patent: 5109119 (1992-04-01), Reichert et al.
patent: 5153265 (1992-10-01), Shadle et al.
patent: 5157736 (1992-10-01), Boyer et al.
patent: 5218092 (1993-06-01), Sasaki et al.
patent: 5265030 (1993-11-01), Skolnick et al.
patent: 5307287 (1994-04-01), Cramer, III et al.
patent: 5386507 (1995-01-01), Teig et al.
patent: 5424963 (1995-06-01), Turner et al.
patent: 5448498 (1995-09-01), Namiki et al.
patent: 5555366 (1996-09-01), Teig et al.
patent: 5581476 (1996-12-01), Osslund
patent: 5597562 (1997-01-01), Maruyama
patent: 5738849 (1998-04-01), Bauer et al.
patent: 5772992 (1998-06-01), Bauer et al.
patent: 5790421 (1998-08-01), Osslund
patent: 5817486 (1998-10-01), Bauer et al.
patent: 5824784 (1998-10-01), Kinstler et al.
patent: 5858347 (1999-01-01), Bauer et al.
patent: 5883230 (1999-03-01), Schendel
patent: 5997860 (1999-12-01), Bauer et al.
patent: 6017523 (2000-01-01), Bauer et al.
patent: 6022535 (2000-02-01), Bauer et al.
patent: 6030812 (2000-02-01), Bauer et al.
patent: 6051217 (2000-04-01), Bauer et al.
patent: 6057133 (2000-05-01), Bauer et al.
patent: 6060047 (2000-05-01), Bauer et al.
patent: 6066318 (2000-05-01), Bauer et al.
patent: 6074639 (2000-06-01), Bauer et al.
patent: 6093395 (2000-07-01), Bauer et al.
patent: 6100070 (2000-08-01), Zurfluh et al.
patent: 6132991 (2000-10-01), Bauer et al.
patent: 6153183 (2000-11-01), Bauer et al.
patent: 6555660 (2003-04-01), Nissen et al.
patent: 2004/0137557 (2004-07-01), DeFrees et al.
patent: 76380/91 (1991-11-01), None
patent: 10948/92 (1992-08-01), None
patent: 0 697433 (1998-10-01), None
patent: 0 243 153 (1976-10-01), None
patent: 0 256 843 (1988-02-01), None
patent: 0 272 703 (1988-06-01), None
patent: 0 370 205 (1989-09-01), None
patent: 0 335 423 (1989-10-01), None
patent: 0 344 796 (1989-12-01), None
patent: 0 456 200 (1991-11-01), None
patent: 0 459 630 (1991-12-01), None
patent: 0 473 268 (1992-03-01), None
patent: 0 490 584 (1992-06-01), None
patent: 2 213 821 (1989-08-01), None
patent: 911696 (1991-08-01), None
patent: 911786 (1991-08-01), None
patent: WO-85/00817 (1985-02-01), None
patent: WO-87/01132 (1987-02-01), None
patent: WO-88/01775 (1988-03-01), None
patent: WO-89/05824 (1990-02-01), None
patent: WO-90/12874 (1990-11-01), None
patent: WO-92/04455 (1992-03-01), None
patent: WO-93/25687 (1993-12-01), None
patent: WO-95/20976 (1995-08-01), None
patent: WO-95/20977 (1995-08-01), None
patent: WO-95/21254 (1995-08-01), None
patent: WO-95/27732 (1995-10-01), None
patent: WO-96/23888 (1996-08-01), None
patent: WO-97/12977 (1997-04-01), None
patent: WO-97/12978 (1997-04-01), None
patent: WO-97/12985 (1997-04-01), None
patent: WO-98/17810 (1998-04-01), None
patent: WO-98/18923 (1998-05-01), None
patent: WO-98/18924 (1998-05-01), None
patent: WO-98/46750 (1998-10-01), None
patent: WO-95/21197 (1999-09-01), None
patent: WO-00/18905 (2000-04-01), None
Caliceti et al, Pharmacokentics of pegylated interferon: what is misleading?, Digestive and Liver Diseases, 36 suppl. 3, 2004, pp. s334-s339.
Abdel-Meguid et al.,PNAS-USA, 84:6434-6437 (1987).
Abrahmsen et al.,Biochem., 30:4151-4159 (1991).
Baudys, et al. “Physical Stabilization of Insulin by Glycosylation,” Journal of Pharmaceutical Sciences, vol. 84, No. 1, pp. 28-33 (1995).
Bazan,Immunology Today, 11:350-354 (1990).
Bowie et al.,Science, 247:1306-1310 (1990).
Carter et al.,J. Biol. Chem., 254:12219-12223 (1979).
Carter et al.,J. Cryst. Growth, 90:60-73 (1988).
Carter, et al., J. of Leukocyte Biology, vol. 75, p. 515-522 (2004).
Cox et al.,J. Appl. Crystallogr., 20:366-373 (1987).
Creighton,Proteins, Structures, &Molecular Principles, W.H. Freeman & Co., New York, p. 216 (1984).
Cunningham et al.,Science, 244:1081-1084 (1989).
Dickerson et al.,The Structure and Action of Proteins, Benjamin/Cummings Publ. Co., Califomia, p. 19 (1969).
Diederichs et al.,Science, 254:1779-1782 (1991).
Feng et al.,Biochemistry, 38:4553-4563 (1999).
Francis,Focus on Growth Factors, 3:4-10 (1992).
Gabrilove,J. Seminars in Hematology, 26:1-14 (1989).
GenBank Report re G-CSF.
Hill et al.,PNAS-USA, 90:5167-5171 (1993).
Huse et al.,Science, 246:1275-1281 (1989).
Ishikawa et al.,Cell Structure and Function, 17:61-65 (1992).
Jancarik et al.,J. Appl. Crystallogr., 24:409 (1991).
Jones et al.,Bailliere's Clinical Hematology, 2:83-111 (1989).
Karplus,Protein Engineering, 35-44 (1987).
Kuga et al.,Biochem. Biophy. Res. Comm., 159:103-111 (1989).
Layton et al.,J. Cell. Biochem., Suppl. 17B:78 (1993).
Layton et al.,J.Biochemistry, 266:23815-23823 (1991).
Li et al.,J. Biochem., 268:22377-22384 (1993).
Lieshke et al.,N. Engl. J. Med., 327:28-34 (1992).
Lieshke et al.,N. Engl. J. Med., 327:99-106 (1992).
Lonejay et al.,J. Mol. Biol., 234:640-653 (1993).
Lu et al.,Arch. Biochem. Biophys., 268:81-92 (1989).
McKay,Science, 257:1673-1677 (1992).
McWherter et al.,Biochemistry, 38:4564-4571 (1999).
Moore et al.,PNAS-USA, 84:7134-7138 (1987).
Nagata et al.,EMBO J., 5:575-581 (1986).
Najahara et al.,J. Mol. Biol., 214:25-26 (1990).
Ngo et al.,The Protein Folding Problem and Tertiary Structure Prediction, K. Merz and S. LeGrand, Eds., Birkhauser, Boston, p. 491-495 (1994).
Nicola et al.,Blood, 54:614-627 (1979).
Nicola,Ann. Rev. Biochem., 58:45-77 (1989).
No author listed,J. Cryst. Growth, 90:318-324 (1988).
Olson et al.,Pour La Science, 183:76-82 (1993).
Osslund et al., Dissertation Abstracts International B., 54:1239 (1993).
Pandit et al.,Science, 258:1358-1362 (1992).
Parry et al.,J. Molecular Recognition, 8:107-110 (1988).
Powers et al.,Science, 256:1673-1677 (1992).
Querol, et al. “Effect of glycosylation of recombinant human granulocytic colony-stimulating factor on expansion cultures of umbilical cord blood CD34+ cells,” Haematologica, 84:493-498 (1999).
Rastetter,Trends in Biotech., 1:80-84 (1983).
Remington's Pharmaceutical Science, 18th Ed., Mack Publishing Co., pp. 1435-1712 (1990).
Schulz et al.,Principles of Protein Structure, Springier-Verlag, New York, p. 14-16 (1979).
Senda et al.,EMBO J., 11:3193-3201 (1992).
Sinclair, et al., “Glycoengineering: The Effect of Glycosylation on the Properties of Therapeutic Proteins,” Journal of Pharmaceutical Sciences, vol. 94, No. 8, pp. 1626-1635 (2005).
Smith et al.,J. Mol. Biol., 224:899-904 (1992).
Souza et al.,Science, 232:61-65 (1986).
Stryer,Biochemistry, 3rd Ed., W.H. Freeman & Co., New York (1988).
Tanaka, et al., “Pharmacokinetics of Recombinant Human Granulocyte Colony-Stimulating Factor Conjugated to Polyethylene Glycol in Rats,” Cancer Research, vol. 15, No. 14, p. 3710-3714 (Jul. 1991).
Tsuchiya et al.,PNAS-USA, 83:7633-7637 (1986).
Vos et al.,Science, 255:305-312 (1992).
Weber et al.,Advances in Protein Chemistry, 41:1-36 (1991).
Weber,J. Appl. Crystallogr., 20:366-373 (1987).
Well et al.,Biochemistry, 8509-8579 (1990).
Welte et al.,PNAS-USA, 82:1526-1530 (1985).
White et al.,Principles of Biochem., 6:156-158 (1978).
Wormald, et al. “Glycoproteins: glycan presentation and protein-fold stability,” Structure, vol. 7, No. 1, pp. R155-R160 (1999).
Zink et al.,Biochem., 33:8453-8463 (1994).
Amgen Inc.
Chandra Gyan
Marshall & Gerstein & Borun LLP
LandOfFree
Modified G-CSF polypeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified G-CSF polypeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified G-CSF polypeptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4310376